UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000018302
Receipt No. R000021181
Scientific Title Study on risk reducing bilateral salpingo-oophorectomy (RRSO) for BRCA1/2 mutation carriers
Date of disclosure of the study information 2015/08/01
Last modified on 2020/01/17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on risk reducing bilateral salpingo-oophorectomy (RRSO) for BRCA1/2 mutation carriers
Acronym Study on RRSO for BRCA1/2 mutation carriers
Scientific Title Study on risk reducing bilateral salpingo-oophorectomy (RRSO) for BRCA1/2 mutation carriers
Scientific Title:Acronym Study on RRSO for BRCA1/2 mutation carriers
Region
Japan

Condition
Condition hereditary breast and ovarian cancer
Classification by specialty
Breast surgery Obsterics and gynecology
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 To evaluate the safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Perioperative complications related to risk reducing salpingo-oophorectomy
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 risk reducing salpingo-oophorectomy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
35 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria 1. BRCA1/2 mutant carriers
2. Informed consent
Key exclusion criteria 1. Women who diseres having babies
2. Women with ovarian or tubal cancer
3. Physician decision
Target sample size 5

Research contact person
Name of lead principal investigator
1st name Yasushi
Middle name
Last name IIDA
Organization The Jikei university, school of medicine
Division name Department of Obstetrics and Gynecology
Zip code 1058471
Address 3-19-18 Nishi-shinbashi Minato-ku, Tokyo, Japan
TEL +81-3-3433-1111
Email surf-side@hotmail.co.jp

Public contact
Name of contact person
1st name Yasushi
Middle name
Last name IIDA
Organization The Jikei university, school of medicine
Division name Department of Obstetrics and Gynecology
Zip code 1058471
Address 3-19-18 Nishi-shinbashi Minato-ku, Tokyo, Japan
TEL +81-3-3433-1111
Homepage URL
Email surf-side@hotmail.co.jp

Sponsor
Institute The Jikei university, school of medicine
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The Jikei university, school of medicine
Address 3-19-18 Nishi-shinbashi Minato-ku, Tokyo, Japan
Tel +81-3-3433-1111
Email surf-side@hotmail.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2015 Year 06 Month 15 Day
Date of IRB
2015 Year 06 Month 08 Day
Anticipated trial start date
2015 Year 08 Month 01 Day
Last follow-up date
2021 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 07 Month 14 Day
Last modified on
2020 Year 01 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021181

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.